0.00Open0.00Pre Close0 Volume0 Open Interest31.00Strike Price0.00Turnover350.00%IV-79.29%PremiumDec 20, 2024Expiry Date13.71Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8935Delta0.0265Gamma1.24Leverage Ratio-0.1205Theta-0.0032Rho-1.10Eff Leverage0.0037Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet